written by reader Tremblay’s Prediction of 80,000% Sales Surge for New Antibiotic to Cure Drug-Resistant Pneumonia

By new2options, October 18, 2016

Any ideas on what stock is being pitched by Tremblay at Biotech Insider Alert as the ”biggest breakthrough since penicillin?”

Here are some teaser quotes from the ad:
”It happens November 4 at 8:30 a.m. Urgent FDA Meeting Poised to Ignite 80,000% Sales
Surge for Tiny Company!”
”… could displace the entire $45 billion antibiotic sector”
”… the FDA is preparing a rare DOUBLE-SHOT DECISION that could unleash a new ”Star Wars” treatment, worth a projected $45 billion.”
”… the company’s CEO, CFO, and Executive VP – have snapped up nearly 90% of available shares alongside institutions… a legendary billionaire has just INCREASED his position in this tiny company by a staggering 571%.”
”… the FDA has given it a rare ”FAST-TRACK” designation… this special FDA classification gives the company a dominant five-year monopoly!”

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.



This site uses Akismet to reduce spam. Learn how your comment data is processed.

Inline Feedbacks
View all comments
October 18, 2016 5:40 am

Looking at the clues I think it may be $AKAO.